Pet cancer research campaign to match donationsMay 17, 2022Morris Animal Foundation’s annual pet cancer research campaign just received a funding boost, thanks to a dollar-for-dollar pledge from two industry players.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Liquid biopsy test can detect 30 types of canine cancer, study showsApril 27, 2022Veterinarians can now benefit from a new tool able to assist in early detection and diagnosis of 30 types of canine cancer.
The future of canine cancer treatmentMarch 15, 2022The use of immunotherapies to treat cancers has become increasingly widespread in human medicine, with some of these promising therapeutics producing remarkable outcomes.
Dogs, kids, and cancer: How dogs are helpingFebruary 18, 2022When it comes to kids, dogs are getting involved in healthcare. Specifically, they are playing a big role in helping pediatric oncologists battle osteosarcoma.Â
Old challenges and new opportunities in treating feline lymphomaFebruary 8, 2022Lymphoma is the most common malignancy in cats and can cause a variety of clinical signs, depending on the site affected and extent of disease.
Canine lymphoma tablets OKed by FDAJanuary 13, 2022Dogs diagnosed with lymphoma can now benefit from newly approved treatment.
Risks and treatments surrounding cancerDecember 3, 2021One of the most common and dreaded diseases we see in small-animal patients is malignant neoplasia.
Liquid biopsy focus of free RACE-approved online CEOctober 26, 2021Veterinary professionals interested in learning about a new tool in cancer detection and characterization can sign up for an upcoming continuing education (CE) course, sponsored by PetDX.
Deadly feline cancer sees new potential treatmentSeptember 30, 2021Researchers are using nanobody-targeted photodynamic therapy to tackle oral squamous cell carcinoma in cats.
Individualized care central to trial canine oral cancer treatment methodSeptember 10, 2021Dogs diagnosed with a rapidly metastatic form of oral cancer may soon have access to a novel alternative treatment, thanks to a newly launched clinical trial.
